NCCN Guidelines Panel Disclosures

Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Therese B Bevers, MD	National Cancer Institute	QuantiaMD	None	NSABP	4/21/2010
Ermelinda Bonaccio, MD	None	None	None	None	9/29/2009
Saundra S. Buys, MD	None	None	None	None	7/1/2009
Kristine E. Calhoun, MD					Pending
Mary B. Daly, MD, PhD, FACP	None	None	None	None	11/2/2009
Peter J Dempsey, MD	None	None	None	None	6/18/2010
William B. Farrar, MD	None	None	None	None	10/29/2009
Judy E. Garber, MD, MPH	None	None	None	None	12/2/2009
Kristina M. Gregory, RN, MSN, OCN	None	None	None	None	8/30/2010
Randall E. Harris, MD, PhD	None	None	None	None	6/18/2010
Alexandra S. Heerdt, MD	None	None	None	None	10/16/2009
Mark Helvie, MD, MS	General Electric	General Electric	None	None	11/4/2009
Linda Hodgkiss, MD	None	None	None	None	4/28/2010
Tamarya L. Hoyt, MD	None	None	None	None	11/16/2009
John G. Huff, MD	None	None	Hologic	None	11/24/2009
Nazanin Khakpour, MD	None	None	None	None	7/1/2009
Seema Khan, MD	None	None	None	None	11/3/2009
Helen Krontiras, MD	None	None	None	None	10/30/2009
Gary H. Lyman, MD, MPH, FRCP	Amgen Inc.	Amgen Inc.	None	None	7/29/2009
Joan S. McClure, MS	None	None	None	None	7/18/2010
Susan Moench, PhD	None	None	None	None	7/29/2010
Barbara Monsees, MD	Hologic	Hologic	None	None	4/20/2010
Elizabeth A. Rafferty, MD	Hologic Inc	None	None	None	11/24/2009
Sara Shaw, MD	None	None	None	None	4/30/2010
Dorothy Shead, MS	None	None	None	None	7/18/2010
Mary Lou Smith, JD, MBA	None	Eli Lilly and Company	None	None	12/30/2009
Theodore N. Tsangaris, MD	None	None	None	None	10/1/2009
Cheryl Williams, MD	None	None	None	None	11/16/2009

NCCN Website Supporters

National Comprehensive Cancer Network

About NCCN